Molecular Pathology of Cancer Group

2018 Activity indicators

  • 2 national competitive public projects - ISCIII
  • 9 private led projects
  • 1 competitive HR contract
  • 18 publications
  • IF: 43.11
  • Publications in Q1: 6 (33%)
  • 1 supervised read thesis
  • National public agency project evaluators: 1 PI
  • Members of national and international editorial committees: 1 PI
  • 4 consensus documents: ESMO; SEOM, SEAP, SEFH
  • 17 visitors received and 56 months' stay
    • Madrid Carlos III University
    • Madrid Complutense University
    • Alcalá University
    • CEP Camino Real

Milestones

  1. Boosting of national alliances: the group has obtained financing from the AECC as part of the consortium of Stable Coordinated Groups ("Targeting the most aggressive type of endometrial carcinoma") and maintains links to CIBERONC.
  2. Participation in the preparation of the national consensus on predictive biomarkers for breast and ovarian cancer.
  3. Collaboration with multiple national and international companies via agreements for the centralised determination of biomarkers in cancer.
  4. Preparation of new NGS protocols for application in research and diagnostics.
  5. Education in research via the supervision of doctoral theses and master theses.

Bibliometrics

  Article Accum. FI Mean FI  Articles Q1 or Q2 % in Q1 or Q2 Articles D1 % on D1
2015 9 37.18 4.33 7 78 1 11
2016 17 94.53 5.56 17 100 8 47
2017 10 46.14 4.61 8 80 3 30
2018 18 43.11 2.40 9 50 0 0
  54 221.0 4.22 41 76 12 22

* Only original articles, editorials, guidelines & reviews

Networks and alliances